An inspection by the Food and Drug Administration at MARS Horsecare US, Inc. in Dalton took place April 23. The review focused on monitoring the facility’s marketed animal drugs, feeds and devices, according to data posted on the FDA’s website.
The resulting report found that MARS Horsecare US, Inc. was not required to make any changes to its management operations.
The FDA regularly inspects facilities nationwide to assess whether workplaces and their products comply with FDA regulations established to protect public health. Inspection outcomes are made available to the public.
As described on its website, the FDA is a federal agency mainly tasked with ensuring the safety and quality of human and animal drugs, biological products, medical supplies and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
